Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure - Quiz - MDSpire

Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure

  • By

  • Xiangyong Li

  • Baoer Wu

  • Huaping Xie

  • Hao Hu

  • Ting Liu

  • Xu You

  • Yanhua Bi

  • Yurong Gu

  • July 8, 2026

  • 0 min

Share

Original Source(s)

Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure

  • by Xiangyong Li, Baoer Wu, Huaping Xie, Hao Hu, Ting Liu, Xu You, Yanhua Bi, Yurong Gu

  • July 8, 2026

Related Content

Secular trends of endoscopic sleeve gastroplasty: analysis of the MBSAQIP database

Elevated serum IgG4 and eosinophilia in a persistent indeterminate biliary stricture with high-risk features: a case report

Impact of powered circular stapling devices on anastomotic leakage rates in colorectal surgery